0 XP   0   0   0

The Valens Company Inc
Buy, Hold or Sell?

I guess you are interested in The Valens Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse The Valens Company Inc

Let's start. I'm going to help you getting a better view of The Valens Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is The Valens Company Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how The Valens Company Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value The Valens Company Inc. The closing price on 2022-01-19 was $1.97 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
The Valens Company Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of The Valens Company Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit The Valens Company Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare The Valens Company Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -60.4% means that $-0.60 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of The Valens Company Inc:

  • The MRQ is -61.0%. The company is making a huge loss. -2
  • The TTM is -60.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-61.0%TTM-60.4%-0.6%
TTM-60.4%YOY-3.6%-56.8%
TTM-60.4%5Y-4,384.6%+4,324.2%
5Y-4,384.6%10Y-4,384.6%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.0%0.7%-61.7%
TTM-60.4%1.0%-61.4%
YOY-3.6%1.7%-5.3%
5Y-4,384.6%0.6%-4,385.2%
10Y-4,384.6%1.2%-4,385.8%
1.1.2. Return on Assets

Shows how efficient The Valens Company Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare The Valens Company Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -5.3% Return on Assets means that The Valens Company Inc generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of The Valens Company Inc:

  • The MRQ is -3.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-5.3%+1.3%
TTM-5.3%YOY0.2%-5.5%
TTM-5.3%5Y-4.3%-1.0%
5Y-4.3%10Y-4.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%0.2%-4.1%
TTM-5.3%0.2%-5.5%
YOY0.2%0.1%+0.1%
5Y-4.3%-0.1%-4.2%
10Y-4.3%0.2%-4.5%
1.1.3. Return on Equity

Shows how efficient The Valens Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare The Valens Company Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -5.3% Return on Equity means the company generated $-0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of The Valens Company Inc:

  • The MRQ is -5.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-6.8%+1.5%
TTM-6.8%YOY0.1%-7.0%
TTM-6.8%5Y-4.9%-2.0%
5Y-4.9%10Y-4.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%0.8%-6.1%
TTM-6.8%0.6%-7.4%
YOY0.1%0.6%-0.5%
5Y-4.9%0.1%-5.0%
10Y-4.9%0.5%-5.4%

1.2. Operating Efficiency of The Valens Company Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient The Valens Company Inc is operating .

  • Measures how much profit The Valens Company Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare The Valens Company Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -77.2% means the company generated $-0.77  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of The Valens Company Inc:

  • The MRQ is -77.2%. The company is operating very inefficient. -2
  • The TTM is -73.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-77.2%TTM-73.6%-3.6%
TTM-73.6%YOY12.8%-86.4%
TTM-73.6%5Y-2,905.4%+2,831.8%
5Y-2,905.4%10Y-2,905.4%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-77.2%3.5%-80.7%
TTM-73.6%2.3%-75.9%
YOY12.8%3.9%+8.9%
5Y-2,905.4%3.5%-2,908.9%
10Y-2,905.4%1.9%-2,907.3%
1.2.2. Operating Ratio

Measures how efficient The Valens Company Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 2.39 means that the operating costs are $2.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of The Valens Company Inc:

  • The MRQ is 2.391. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.619. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.391TTM2.619-0.228
TTM2.619YOY1.444+1.175
TTM2.6195Y30.453-27.834
5Y30.45310Y30.4530.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3911.480+0.911
TTM2.6191.435+1.184
YOY1.4441.383+0.061
5Y30.4531.363+29.090
10Y30.4531.160+29.293

1.3. Liquidity of The Valens Company Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if The Valens Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.42 means the company has $2.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of The Valens Company Inc:

  • The MRQ is 2.419. The company is able to pay all its short-term debts. +1
  • The TTM is 3.296. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.419TTM3.296-0.876
TTM3.296YOY4.177-0.882
TTM3.2965Y13.423-10.127
5Y13.42310Y13.4230.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4191.887+0.532
TTM3.2961.900+1.396
YOY4.1772.104+2.073
5Y13.4232.156+11.267
10Y13.4231.840+11.583
1.3.2. Quick Ratio

Measures if The Valens Company Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 1.04 means the company can pay off $1.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of The Valens Company Inc:

  • The MRQ is 1.045. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.280. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.045TTM1.280-0.235
TTM1.280YOY1.608-0.328
TTM1.2805Y6.159-4.879
5Y6.15910Y6.1590.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0450.641+0.404
TTM1.2800.784+0.496
YOY1.6080.809+0.799
5Y6.1590.838+5.321
10Y6.1590.834+5.325

1.4. Solvency of The Valens Company Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of The Valens Company Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.26 means that The Valens Company Inc assets are financed with 25.7% credit (debt) and the remaining percentage (100% - 25.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of The Valens Company Inc:

  • The MRQ is 0.257. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.223. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.223+0.034
TTM0.223YOY0.251-0.028
TTM0.2235Y0.165+0.058
5Y0.16510Y0.1650.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2570.429-0.172
TTM0.2230.412-0.189
YOY0.2510.391-0.140
5Y0.1650.390-0.225
10Y0.1650.396-0.231
1.4.2. Debt to Equity Ratio

Measures if The Valens Company Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 34.6% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of The Valens Company Inc:

  • The MRQ is 0.346. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.289. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.289+0.057
TTM0.289YOY0.345-0.056
TTM0.2895Y0.219+0.070
5Y0.21910Y0.2190.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3460.688-0.342
TTM0.2890.677-0.388
YOY0.3450.624-0.279
5Y0.2190.678-0.459
10Y0.2190.689-0.470

2. Market Valuation of The Valens Company Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in The Valens Company Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -24.42 means the investor is paying $-24.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of The Valens Company Inc:

  • The EOD is -6.701. Company is losing money. -2
  • The MRQ is -24.420. Company is losing money. -2
  • The TTM is -26.317. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.701MRQ-24.420+17.718
MRQ-24.420TTM-26.317+1.897
TTM-26.317YOY2,584.437-2,610.755
TTM-26.3175Y849.350-875.667
5Y849.35010Y849.3500.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-6.7010.297-6.998
MRQ-24.4200.416-24.836
TTM-26.3171.360-27.677
YOY2,584.4373.493+2,580.944
5Y849.3506.176+843.174
10Y849.3506.668+842.682
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of The Valens Company Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of The Valens Company Inc:

  • The MRQ is 0.003. Very good. +2
  • The TTM is 0.050. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.003TTM0.050-0.047
TTM0.050YOY-12.754+12.804
TTM0.0505Y-2.511+2.561
5Y-2.51110Y-2.5110.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0030.003+0.000
TTM0.0500.020+0.030
YOY-12.7540.032-12.786
5Y-2.5110.026-2.537
10Y-2.5110.029-2.540

2. Books
2.3. Price to Book Ratio

Measures if the stock price of The Valens Company Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 5.48 means the investor is paying $5.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of The Valens Company Inc:

  • The EOD is 1.505. Good. +1
  • The MRQ is 5.484. Seems overpriced? -1
  • The TTM is 5.455. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD1.505MRQ5.484-3.979
MRQ5.484TTM5.455+0.028
TTM5.455YOY5.687-0.231
TTM5.4555Y3.714+1.741
5Y3.71410Y3.7140.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.5051.424+0.081
MRQ5.4841.617+3.867
TTM5.4552.042+3.413
YOY5.6872.274+3.413
5Y3.7142.006+1.708
10Y3.7141.538+2.176

3. Summary

3.1. Key Performance Indicators

The key performance indicators of The Valens Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--1.3091.108+18%1.097+19%0.735+78%0.735+78%
Book Value Per Share Growth--0.2450.053+361%0.274-11%0.164+50%0.164+50%
Current Ratio--2.4193.296-27%4.177-42%13.423-82%13.423-82%
Debt To Asset Ratio--0.2570.223+15%0.251+2%0.165+55%0.165+55%
Debt To Equity Ratio--0.3460.289+20%0.345+0%0.219+58%0.219+58%
Dividend Per Share----0%-0%-0%-0%
Eps---0.069-0.073+6%0.001-6908%-0.040-42%-0.040-42%
Eps Growth---7331.181-7071.479-4%-102.091-99%-5677.601-23%-5677.601-23%
Gains Per Share--0.2450.053+361%0.274-11%0.164+50%0.164+50%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.610-0.604-1%-0.036-94%-43.846+7091%-43.846+7091%
Operating Margin---0.772-0.736-5%0.128-703%-29.054+3664%-29.054+3664%
Operating Ratio--2.3912.619-9%1.444+66%30.453-92%30.453-92%
Pb Ratio1.505-264%5.4845.455+1%5.687-4%3.714+48%3.714+48%
Pe Ratio-6.701+73%-24.420-26.317+8%2584.437-101%849.350-103%849.350-103%
Peg Ratio--0.0030.050-93%-12.754+382984%-2.511+75474%-2.511+75474%
Price Per Share1.970-264%7.1796.059+18%6.231+15%6.264+15%6.264+15%
Quick Ratio--1.0451.280-18%1.608-35%6.159-83%6.159-83%
Return On Assets---0.039-0.053+34%0.002-2064%-0.043+8%-0.043+8%
Return On Equity---0.053-0.068+29%0.001-4526%-0.049-8%-0.049-8%
 EOD+2 -1MRQTTM+8 -10YOY+3 -155Y+8 -1010Y+8 -10

3.2. Fundamental Score

Let's check the fundamental score of The Valens Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.701
Price to Book Ratio (EOD)Between0-11.505
Net Profit Margin (MRQ)Greater than0-0.610
Operating Margin (MRQ)Greater than0-0.772
Quick Ratio (MRQ)Greater than11.045
Current Ratio (MRQ)Greater than12.419
Debt to Asset Ratio (MRQ)Less than10.257
Debt to Equity Ratio (MRQ)Less than10.346
Return on Equity (MRQ)Greater than0.15-0.053
Return on Assets (MRQ)Greater than0.05-0.039
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of The Valens Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.658
Ma 20Greater thanMa 502.444
Ma 50Greater thanMa 1003.143
Ma 100Greater thanMa 2004.388
OpenGreater thanClose2.090
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2021-08-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets325,832
Total Liabilities83,677
Total Stockholder Equity242,155
 As reported
Total Liabilities 83,677
Total Stockholder Equity+ 242,155
Total Assets = 325,832

Assets

Total Assets325,832
Total Current Assets138,423
Long-term Assets138,423
Total Current Assets
Cash And Cash Equivalents 30,958
Short-term Investments 14,170
Net Receivables 45,620
Inventory 39,052
Other Current Assets 17,121
Total Current Assets  (as reported)138,423
Total Current Assets  (calculated)146,921
+/- 8,498
Long-term Assets
Property Plant Equipment 70,776
Goodwill 40,662
Intangible Assets 75,470
Other Assets 501
Long-term Assets  (as reported)187,409
Long-term Assets  (calculated)187,409
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities57,216
Long-term Liabilities26,461
Total Stockholder Equity242,155
Total Current Liabilities
Short Long Term Debt 7,843
Accounts payable 29,684
Other Current Liabilities 18,148
Total Current Liabilities  (as reported)57,216
Total Current Liabilities  (calculated)55,675
+/- 1,541
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,434
Other Liabilities 20,216
Long-term Liabilities  (as reported)26,461
Long-term Liabilities  (calculated)26,650
+/- 189
Total Stockholder Equity
Common Stock296,948
Retained Earnings -84,394
Other Stockholders Equity 29,601
Total Stockholder Equity (as reported)242,155
Total Stockholder Equity (calculated)242,155
+/-0
Other
Common Stock Shares Outstanding 184,980
Net Invested Capital 251,350
Net Tangible Assets 126,023
Net Working Capital 81,207



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-30
> Total Assets 
53,674
51,101
112,297
124,333
154,751
203,940
201,304
193,857
167,576
199,395
209,984
325,832
325,832209,984199,395167,576193,857201,304203,940154,751124,333112,29751,10153,674
   > Total Current Assets 
32,220
27,668
77,718
88,022
109,311
128,364
119,484
105,750
78,478
106,733
92,971
138,423
138,42392,971106,73378,478105,750119,484128,364109,31188,02277,71827,66832,220
       Cash And Cash Equivalents 
1,727
489
57,016
60,375
49,888
35,580
36,567
30,257
20,344
49,300
23,926
30,958
30,95823,92649,30020,34430,25736,56735,58049,88860,37557,0164891,727
       Short-term Investments 
23,506
20,064
8,506
8,858
8,813
8,706
8,500
0
1,032
0
0
14,170
14,170001,03208,5008,7068,8138,8588,50620,06423,506
       Net Receivables 
2,758
2,011
7,926
16,296
35,080
50,240
36,004
35,524
30,189
32,101
41,445
45,620
45,62041,44532,10130,18935,52436,00450,24035,08016,2967,9262,0112,758
       Inventory 
507
905
2,008
850
14,181
32,708
35,414
33,658
23,142
23,920
24,074
39,052
39,05224,07423,92023,14233,65835,41432,70814,1818502,008905507
       Other Current Assets 
3,323
993
300
800
788
802
1,555
3,580
2,807
656
1,052
17,121
17,1211,0526562,8073,5801,5558027888003009933,323
   > Long-term Assets 
0
0
34,579
36,311
45,440
75,576
81,820
88,107
89,098
92,662
117,013
187,409
187,409117,01392,66289,09888,10781,82075,57645,44036,31134,57900
       Property Plant Equipment 
7,189
3,168
21,026
23,106
26,374
34,127
42,207
50,329
53,156
57,548
65,997
70,776
70,77665,99757,54853,15650,32942,20734,12726,37423,10621,0263,1687,189
       Goodwill 
0
0
0
0
4,123
4,123
4,123
4,123
4,123
4,123
21,814
40,662
40,66221,8144,1234,1234,1234,1234,1234,1230000
       Intangible Assets 
14,266
13,909
13,552
13,204
14,943
37,326
35,490
33,655
31,819
30,100
28,305
75,470
75,47028,30530,10031,81933,65535,49037,32614,94313,20413,55213,90914,266
       Other Assets 
0
0
0
0
0
0
0
0
0
891
897
501
501897891000000000
> Total Liabilities 
961
1,277
1,457
3,885
22,017
60,356
59,134
53,104
40,190
39,743
41,308
83,677
83,67741,30839,74340,19053,10459,13460,35622,0173,8851,4571,277961
   > Total Current Liabilities 
961
1,277
1,457
3,885
21,135
48,013
28,985
22,300
19,861
28,954
29,744
57,216
57,21629,74428,95419,86122,30028,98548,01321,1353,8851,4571,277961
       Short Long Term Debt 
0
0
0
0
0
0
1,837
1,923
2,025
9,000
8,500
7,843
7,8438,5009,0002,0251,9231,837000000
       Accounts payable 
952
1,277
1,457
3,533
14,834
35,762
20,788
13,781
14,396
14,468
16,397
29,684
29,68416,39714,46814,39613,78120,78835,76214,8343,5331,4571,277952
       Other Current Liabilities 
9
30
168
431
6,301
11,923
6,024
5,801
2,893
4,930
4,327
18,148
18,1484,3274,9302,8935,8016,02411,9236,301431168309
   > Long-term Liabilities 
0
0
0
0
882
12,343
30,149
30,804
20,329
10,789
11,564
26,461
26,46111,56410,78920,32930,80430,14912,3438820000
       Other Liabilities 
0
0
0
0
882
9,801
10,094
9,705
9,513
7,030
7,905
20,216
20,2167,9057,0309,5139,70510,0949,8018820000
> Total Stockholder Equity
52,713
49,824
110,840
120,448
132,734
143,584
142,170
140,753
127,386
159,652
168,676
242,155
242,155168,676159,652127,386140,753142,170143,584132,734120,448110,84049,82452,713
   Common Stock
65,049
21,798
144,970
148,630
153,826
160,227
160,770
161,315
162,585
195,692
212,970
296,948
296,948212,970195,692162,585161,315160,770160,227153,826148,630144,97021,79865,049
   Retained Earnings -84,394-71,595-62,936-56,783-40,148-37,086-33,514-36,057-40,523-46,416-35,887-29,521
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
17,185
6,710
12,286
12,341
14,965
16,871
18,486
19,586
21,584
26,896
27,301
29,601
29,60127,30126,89621,58419,58618,48616,87114,96512,34112,2866,71017,185



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2020-11-30)

Gross Profit (+$)
totalRevenue83,778
Cost of Revenue-58,054
Gross Profit25,72425,724
 
Operating Income (+$)
Gross Profit25,724
Operating Expense-103,878
Operating Income-20,100-78,154
 
Operating Expense (+$)
Research Development2,189
Selling General Administrative33,445
Selling And Marketing Expenses-
Operating Expense103,87835,634
 
Net Interest Income (+$)
Interest Income496
Interest Expense-0
Net Interest Income-901496
 
Pretax Income (+$)
Operating Income-20,100
Net Interest Income-901
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-22,591-18,510
EBIT - interestExpense = -20,671
-22,591
-20,682
Interest Expense0
Earnings Before Interest and Taxes (ebit)-20,671-22,591
Earnings Before Interest and Taxes (ebitda)-11,141
 
After tax Income (+$)
Income Before Tax-22,591
Tax Provision--1,909
Net Income From Continuing Ops-20,682-20,682
Net Income-20,682
Net Income Applicable To Common Shares-20,682
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,819
Total Other Income/Expenses Net-1,590901
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UPSL.TA
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UPSL.TA.

UPSL.TA Daily Candlestick Chart
ZMH.TA
3 hours ago

I found you a Bullish Three Line Strike Candle Pattern on the daily chart of ZMH.TA.

ZMH.TA Daily Candlestick Chart
SRFT.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SRFT.TA.

SRFT.TA Daily Candlestick Chart
NFTA.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
MSLA.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MSLA.TA.

MSLA.TA Daily Candlestick Chart
CAST.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CAST.TA.

CAST.TA Daily Candlestick Chart
HRON.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HRON.TA.

HRON.TA Daily Candlestick Chart
NAWI.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NAWI.TA.

NAWI.TA Daily Candlestick Chart
IBI.TA
3 hours ago

I found you a Death Cross on the daily chart of IBI.TA.

IBI.TA Daily Candlestick Chart
CBI.TA
3 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of CBI.TA.

CBI.TA Daily Candlestick Chart
MRIN.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MRIN.TA.

MRIN.TA Daily Candlestick Chart
ANLT.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ANLT.TA.

ANLT.TA Daily Candlestick Chart
ASHG.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASHG.TA.

ASHG.TA Daily Candlestick Chart
WTS.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WTS.TA.

WTS.TA Daily Candlestick Chart
VCTR.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCTR.TA.

VCTR.TA Daily Candlestick Chart
TOPS.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TOPS.TA.

TOPS.TA Daily Candlestick Chart
WSMK.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WSMK.TA.

WSMK.TA Daily Candlestick Chart
SPEN.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPEN.TA.

SPEN.TA Daily Candlestick Chart
PRSK.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PRSK.TA.

PRSK.TA Daily Candlestick Chart
MZTF.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MZTF.TA.

MZTF.TA Daily Candlestick Chart
OPK.TA
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of OPK.TA.

OPK.TA Daily Candlestick Chart
AMAN.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AMAN.TA.

AMAN.TA Daily Candlestick Chart
MGOR.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MGOR.TA.

MGOR.TA Daily Candlestick Chart
MDIN-L.TA
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MDIN-L.TA.

MDIN-L.TA Daily Candlestick Chart